PharmAla Biotech Holdings Inc. (“PharmAla” or the “Company”) (CSE: MDMA) (OTC: MDXXF), a biotechnology company focused on the research, development, and manufacturing of LaNeo™ MDMA and novel ...

Moderna announced Wednesday that the Trump administration has canceled a major contract worth nearly $700 million for the ...

This is the web version of STAT’s special newslette r from the annual meeting of the American Society of Oncology. For more ...

D Molecular Therapeutics (Nasdaq: FDMT, 4DMT or the Company), a leading late-stage biotechnology company advancing durable and disease-targeted therapeutics with potential to transform treatment ...

SCIEX, a global leader in life science analytical technologies and operating company of Danaher Corporation (NYSE: DHR), and ...

An colon cancer study highlighted the importance of the National Cancer Institute, while cancer doctors got a look at a ...

PharmAla Biotech (CSE:MDMA) issued a public warning after discovering that unknown parties are illegally marketing a nasal ...

The new SCIEX OS software version 4.0 is the latest evolution of its powerful software platform. This new Microsoft Windows 11 compatible release drives operability enhancements with speed and ...

Canada], May 29: Mapmygenome, an AI-driven leader in genomics and personalized health, announced the strategic acquisition of ...

At ASMS 2025, SCIEX, a global leader in life science analytical technologies and operating company of Danaher Corporation ...

Equity Insider News Commentary – With early onset cancer rates on the rise and funding being cut to NIH, the future for cancer patients is increasingly being shaped not by public institutions, but by ...